1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

OMF: A Holiday message from Dr. Ron Davis, 2018

Discussion in 'ME/CFS research news' started by Eagles, Dec 17, 2018.

  1. Eagles

    Eagles Senior Member (Voting Rights)

    Messages:
    176
    Sly Saint, Sean, chrisb and 11 others like this.
  2. Sunshine3

    Sunshine3 Senior Member (Voting Rights)

    Messages:
    622
    So does this mean that all the information they thought they had on metabolic trap is questionable or wrong? I'm not sure how to interpret what Dr.Davis said?
     
  3. Jim001

    Jim001 Established Member (Voting Rights)

    Messages:
    53
    Sounds like the metabolic trap is back to being an untested hypothesis. :(
     
    Sunshine3 likes this.
  4. Sunshine3

    Sunshine3 Senior Member (Voting Rights)

    Messages:
    622
  5. Trish

    Trish Moderator Staff Member

    Messages:
    52,331
    Location:
    UK
    My understanding of what he said about the metabolic trap is that there is a delay in testing the hypothesis, because the instruments they were planning to use to carry out the tests don't give accurate enough results, so they are having to design better ways to get the accuracy they need. So it's not that the information was wrong, it's just that they haven't been able to get high enough quality data yet to test it properly.
     
    leokitten, Sean, Wonko and 13 others like this.
  6. Stewart

    Stewart Senior Member (Voting Rights)

    Messages:
    238
    Towards the end of his presentation at the recent OMF symposium Phair said that they'd already started testing the hypothesis and showed the early results having tested 6 patients with ME/CFS (and he intimated that this testing used a mass spectrometer). I think we have to assume that the results he showed (the three graphs that appeared to support his testable predictions about cellular tryptophan and kyneurenine and the kyn/trp ratio) aren't reliable - at least until we hear more from the OMF.
     
    Jim001 and Barry like this.
  7. voner

    voner Senior Member (Voting Rights)

    Messages:
    222
    One thing I have noticed about Ron Davis’s OMF work is if there is no way to test what he wants to test, he will attempt to try to develop a test. I suspect that’s a difference from having private funding rather than government funding. He has the leeway to do this.
     
    daftasabrush likes this.
  8. FMMM1

    FMMM1 Senior Member (Voting Rights)

    Messages:
    2,648
    I wonder if it's variability in the sample or variability in the instrument; I assume that it's variability in the instrument. E.g. test same patient multiple times and the results vary (e.g. you can't reliably extract the PBMCs/extract tryptophan from PBMCs) or test the same sample multiple times and the results vary (e.g. instrument - mass spectrometer variability).

    We need public i.e. government funding;most significant science breakthroughs have their origin in publicly funded research. The gulf war veterans are getting some funding but ME/CFS is getting very little. The big pharmaceutical firms may come on board at some point but until then we need public funding.
     
    Hoopoe likes this.
  9. Aroa

    Aroa Established Member (Voting Rights)

    Messages:
    64
    Location:
    Spain
    I think OMF needs advice from a communication specialist. It should be considered as an investment .
     
    daftasabrush likes this.
  10. Sunshine3

    Sunshine3 Senior Member (Voting Rights)

    Messages:
    622
    Why so?
     
    chrisb likes this.

Share This Page